EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mass spectrometric detection of neutrophil elastase cleaved corticosteroid binding globulin and its association with Asn347 site glycosylation, in septic shock patients

Jessica H Lee, Zeynep Sumer-Bayraktar, Parul Mittal, Leigh Donnellan, Clifford Young, R Louise Rushworth, John G Lewis, Marni Nenke, Wayne Rankin, Manuela Klingler-Hoffman, Peter Hoffmann, Morten Thaysen-Andersen und 2 weitere

Clinica Chimica Acta · 2025

DOI: 10.1016/j.cca.2024.120108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinica Chimica Acta, 2025. Verfasst von Jessica H Lee und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Adelaide, Australia; Endocrine and Metabolic Unit, Royal Adelaide Hospital, Australia. Electronic address: Jess…. Hauptthemen laut MEDLINE: Shock, Septic, Leukocyte Elastase, Transcortin, Asparagine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Adelaide Hospital Research Fund, Royal Adelaide Hospital, RACP Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Corticosteroid-binding globulin (CBG) modulates tissue cortisol availability via modification of cortisol:CBG binding affinity in response to multiple factors, including neutrophil elastase (NE) cleavage of the reactive centre loop (RCL), converting high affinity CBG (haCBG) to low affinity CBG (laCBG). In vitro, glycosylation of the RCL at Asn347 affects NE cleavage susceptibility. To date, no direct measurement of laCBG, which would verify NE cleavage, has been reported. OBJECTIVE: To measure serum laCBG in septic shock patients by mass spectrometry to confirm NE cleavage in vivo, with Asn347 site glycosylation profiling to determine its impact on NE cleavage, and determine effect of %laCBG on septic shock clinical outcome. METHODS: Serum from septic shock patients from a tertiary hospital intensive care unit was analysed by mass spectrometry for CBG affinity forms and Asn347 glycosylation profile, following CBG immunoprecipitation. Data was correlated with septic shock clinical outcome. RESULTS: N-terminal peptide of NE cleaved RCL (AVLQLNEEGVDTAGSTGV) was consistently detected in patient serum, although at low concentrations. Mean %laCBG/total CBG was 0.23 % in septic shock (range = 0.07-0.74 %, SD = 0.12 %); in comparison healthy controls mean %laCBG was 0.04 % (range 0.02-0.08 %, SD = 0.03 %). There was a negative correlation between %laCBG and serum concentrations of CBG with triantennary Asn347 glycans; TS3 (r = -0.190, p = 0.040) and TS3F (r = -0.252, p = 0.006). CONCLUSIONS: NE cleaved CBG (laCBG) is present in septic shock patient serum, and %laCBG correlates with Asn347 glycosylation occupancy and composition. However, serum %laCBG did not correlate with septic shock clinical outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shock, SepticLeukocyte ElastaseTranscortinAsparagineHumansGlycosylationMaleFemaleMass SpectrometryMiddle AgedAged

Stichwörter der Autor:innen

CBGCorticosteroid binding globulinCortisolN-glycosylationNeutrophil elastaseSeptic shocklow affinity CBG

Substanzen

Leukocyte ElastaseTranscortinAsparagine

Autor:innen und Institutionen

  • Department of Medicine, University of Adelaide, Australia; Endocrine and Metabolic Unit, Royal Adelaide Hospital, Australia. Electronic address: Jessica.Lee@adelaide.edu.au.
  • School of Natural Sciences, Macquarie University, Australia.
  • Clinical and Health Sciences Unit, University of South Australia, Australia.
  • School of Medicine, Sydney, The University of Notre Dame, Australia.
  • Canterbury Health Laboratories and Department of Pathology, University of Otago, Christchurch.
  • Department of Medicine, University of Adelaide, Australia; Endocrine and Metabolic Unit, Royal Adelaide Hospital, Australia; Endocrine and Diabetes Services, The Queen Elizabeth Hospital, Australia.

Förderung

  • Royal Adelaide Hospital Research Fund
  • Royal Adelaide Hospital
  • RACP Foundation

Zitieren

APA

Lee, J. H., Sumer-Bayraktar, Z., Mittal, P., Donnellan, L., Young, C., Rushworth, R. L., Lewis, J. G., Nenke, M., Rankin, W., Klingler-Hoffman, M., Hoffmann, P., Thaysen-Andersen, M., Torpy, D. J., & Meyer, E. J. (2025). Mass spectrometric detection of neutrophil elastase cleaved corticosteroid binding globulin and its association with Asn347 site glycosylation, in septic shock patients. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2024.120108

Vancouver

Lee JH, Sumer-Bayraktar Z, Mittal P, Donnellan L, Young C, Rushworth RL, et al. Mass spectrometric detection of neutrophil elastase cleaved corticosteroid binding globulin and its association with Asn347 site glycosylation, in septic shock patients. Clinica Chimica Acta. 2025. doi:10.1016/j.cca.2024.120108

BibTeX
@article{Lee2025,
  author = {Lee, Jessica H and Sumer-Bayraktar, Zeynep and Mittal, Parul and Donnellan, Leigh and Young, Clifford and Rushworth, R Louise and Lewis, John G and Nenke, Marni and Rankin, Wayne and Klingler-Hoffman, Manuela and Hoffmann, Peter and Thaysen-Andersen, Morten and Torpy, David J and Meyer, Emily J},
  title = {Mass spectrometric detection of neutrophil elastase cleaved corticosteroid binding globulin and its association with Asn347 site glycosylation, in septic shock patients},
  journal = {Clinica Chimica Acta},
  year = {2025},
  doi = {10.1016/j.cca.2024.120108}
}
Kostenlos starten →